Perrigo

Could a 'creative deal' between Perrigo, Amneal help reinvent both struggling businesses?
Could a 'creative deal' between Perrigo, Amneal help reinvent both struggling businesses?
Fierce Pharma
Perrigo
Amneal
M&A
Flag link:
How Mylan ended as a junior partner in its Pfizer deal
How Mylan ended as a junior partner in its Pfizer deal
Biopharma Dive
Mylan
Pfizer
Perrigo
Teva Pharmaceutical
M&A
Flag link:
Perrigo appoints new CEO, reshuffling leadership for 3rd time since 2016
Perrigo appoints new CEO, reshuffling leadership for 3rd time since 2016
Biopharma Dive
Perrigo
Pharma CEOs
Flag link:
Gottlieb calls out Perrigo for missed postmarket study deadline
Gottlieb calls out Perrigo for missed postmarket study deadline
Biopharma Dive
FDA
Scott Gottlieb
social media
twitter
postmarketing studies
Perrigo
Flag link:
Perrigo postpones launch of generic to Teva’s ProAir
Perrigo postpones launch of generic to Teva’s ProAir
GoinPharma
Perrigo
Teva Pharmaceutical
ProAir
generics
Flag link:
Generic-Drug Companies to Face First Charges in U.S. Probe
Generic-Drug Companies to Face First Charges in U.S. Probe
Bloomberg
generics
Mylan
Perrigo
Teva Pharmaceutical
price fixing
Flag link:
Are Amazon’s Private Label OTC Medications a Stepping Stone to Prescription Drug Sales?
Are Amazon’s Private Label OTC Medications a Stepping Stone to Prescription Drug Sales?
Xtalks
Amazon
OTC
Perrigo
Flag link:
Perrigo sells Chemagis for $110m
Perrigo sells Chemagis for $110m
GoinPharma
Perrigo
Chemagis
M&A
Flag link:
Floundering Perrigo's CEO Hendrickson to depart after rocky 13-month tenure
Floundering Perrigo's CEO Hendrickson to depart after rocky 13-month tenure
Fierce Pharma
Perrigo
Pharma CEOs
John Hendrickson
Flag link:
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit
Fierce Pharma
Teva Pharmaceutical
Perrigo
Sun Pharma
Bayer
dermatology
M&A
Flag link:
GSK, Merck shares win as 2016 brings big moves. Losers? You know who
GSK, Merck shares win as 2016 brings big moves. Losers? You know who
Fierce Pharma
GSK
Merck
Valeant Pharmaceuticals
Endo International
Sagent Pharmaceuticals
Alkermes
Shire
Perrigo
Flag link:
Will Perrigo be Gobbled Up In Consumer Health Consolidation?
Will Perrigo be Gobbled Up In Consumer Health Consolidation?
Bidness, ETC
Perrigo
Reckitt Benckiser
consumer health
M&A
JNJ
P&G
Flag link:
Perrigo Shares Gain After Report Drugmaker Is Close to Deal
Perrigo Shares Gain After Report Drugmaker Is Close to Deal
Bloomberg
Perrigo
M&A
generics
Flag link:
Why Perrigo's Future Is Still Promising
Why Perrigo's Future Is Still Promising
Seeking Alpha
Perrigo
Flag link:
Valeant Slumps as New CEO Faulted by Successor at Perrigo
Valeant Slumps as New CEO Faulted by Successor at Perrigo
Bloomberg
Valeant Pharmaceuticals
Joseph Papa
Perrigo
Pharma CEOs
John Hendrickson
Flag link:
New CEO Won't Fix The Issues Facing Perrigo
New CEO Won't Fix The Issues Facing Perrigo
Seeking Alpha
Pharma CEOs
Perrigo
Joseph Papa
Valeant Pharmaceuticals
Flag link:
From Endo to Allergan: The Sum of Drug Pricing Fears
From Endo to Allergan: The Sum of Drug Pricing Fears
WSJ Online
Endo International
Allergan
Perrigo
generics
Flag link:
Did Perrigo's Papa Leave It As A 'Valeant-Lite'?
Did Perrigo's Papa Leave It As A 'Valeant-Lite'?
Seeking Alpha
Joseph Papa
Pharma CEOs
Valeant Pharmaceuticals
Perrigo
Flag link:
Valeant names ex-Perrigo chief Joseph Papa as CEO
Valeant names ex-Perrigo chief Joseph Papa as CEO
BioPharma Dive
Valeant Pharmaceuticals
Joseph Papa
Pharma CEOs
Perrigo
Flag link:
Perrigo Company Posts Weak Preliminary Results, Appoints New CEO as Papa Joins Valeant Pharmaceuticals
Perrigo Company Posts Weak Preliminary Results, Appoints New CEO as Papa Joins Valeant Pharmaceuticals
Bidness, ETC
Perrigo
Joseph Papa
earnings
Valeant Pharmaceuticals
Flag link:

Pages